NR1D2 and neoplasm: In line with these findings, we performed multiplex immunofluorescence (mIF) on an additional cohort of 17 tumor samples collected before neoCRT, using CD8, TIGIT, and NR1D2 as markers to identify early‐Tex (Figure 2l,m).